Press Releases
Press Release
Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization for Multicenter Phase II Open-label Pilot Study of CardiolRx™ for Recurrent Pericarditis
May 17, 2022
Press Release
Cardiol Therapeutics Announces Year-End 2021 Update on Operations
March 24, 2022
Press Release
Cardiol Therapeutics to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit
March 22, 2022
Press Release
Cardiol Therapeutics Appoints Jennifer M. Chao to its Board of Directors
March 15, 2022
Press Release
Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial
March 01, 2022
Press Release
Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board
January 19, 2022
Press Release
Cardiol Therapeutics Announces Closing of US$50 Million Public Offering
November 05, 2021
Press Release
Cardiol Therapeutics Announces Pricing of Public Offering of Units
November 03, 2021
Press Release
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Units
November 02, 2021
